Liyue Xi (力月西)力月西

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

咪达唑仑是一种在国家药监局注册认定的药品。该药品含有咪达唑仑-c1d9d18d等成分。

该药品关联的活性成分包括:咪达唑仑Mida Zuolun。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:江苏恩华药业股份有限公司Chinese legal name: 江苏恩华药业股份有限公司。

您可以探索含有相同成分的其他药品:咪达唑仑-c1d9d18d成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 力月西) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 咪达唑仑Mida Zuolun.

Manufacturers recorded for this product: 江苏恩华药业股份有限公司Chinese legal name: 江苏恩华药业股份有限公司.

Explore other medicines containing the same ingredient: 咪达唑仑 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 力月西Recorded Chinese name: 力月西
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 15mg15 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 江苏恩华药业股份有限公司Chinese legal name: 江苏恩华药业股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20041869

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20041869

Manufacturer

Chinese legal name: 江苏恩华药业股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20041869

生产企业

江苏恩华药业股份有限公司(国产)

适应症

本品用于各种失眠症的短期治疗,特别适用于入睡困难者或手术前及器械性诊断性检查前用药。

用法用量

口服、一般推荐每日一次,每次7.5毫克。剂量范围7.5~15毫克。 1.成人剂量范围、每晚睡前7.5~15毫克。应从低剂量开始,治疗期限以数天至2周为宜。 2.老年及虚弱病人、推荐剂量为7.5毫克,每日一次。 3.手术及器械性诊断性检查前用药,应在操作前30~60分钟用药。

不良反应

可能出现头晕、乏力、偶见血压下降或腹胀。国外报道偶见过敏性皮疹,短暂顺行性遗忘或长期服用本品可出现躯体性和精神性依赖;骤然停药可出现反跳性失眠。

禁忌

对苯二氮、类药物过敏者;重症肌无力;严重心、肺功能不全者;严重肝功能不全者;睡眠呼吸暂停综合征及儿童患者禁用。

注意事项

1. 应在医师指导下用药;剂量应个体化。
2. 心肺功能及肝,肾功能异常者慎用。
3. 为预防反跳性失眠发生,建议在失眠障碍改善后逐渐减少用量,限定治疗时限。
4. 对酒,药物依赖者慎用。
5. 服药期间,应避免驾驶或其他机械性操作。

贮藏

本品不宜冷冻贮存以防冻裂。

规格

15mg

证据Evidence

  • 批准文号: 国药准字H20041869
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.